Representatives of Fulgent Genetics to Participate in the Piper Jaffray 31st Annual Healthcare Conference
November 25 2019 - 8:00AM
Fulgent Genetics, Inc. (NASDAQ: FLGT) (“Fulgent Genetics” or the
“company”), a provider of comprehensive genetic testing and Next
Generation Sequencing (NGS) solutions, today announced that its
Chairman and Chief Executive Officer Ming Hsieh, Chief Financial
Officer Paul Kim, and Vice President of Commercial Operations
Brandon Perthuis are scheduled to participate in the 31st Annual
Piper Jaffray Healthcare Conference on Wednesday, December 4, 2019
at the Lotte New York Palace Hotel in New York, New York.
These representatives of the company will participate in a
question-and-answer session with the host analyst beginning at
approximately 12:30 p.m. ET.
A live webcast of the question and answer session will be
available on the Investor Relations section of the Fulgent Genetics
website at ir.fulgentgenetics.com. A replay of the webcast will be
accessible at ir.fulgentgenetics.com beginning approximately one
hour following the completion of the event.
About Fulgent Genetics
Fulgent Genetics is a technology company with a focus on
offering comprehensive genetic testing to provide physicians with
clinically actionable diagnostic information they can use to
improve the quality of patient care. The company has developed a
proprietary technology platform that allows it to offer a broad and
flexible test menu and continually expand and improve its
proprietary genetic reference library, while maintaining accessible
pricing, high accuracy and competitive turnaround times. The
company believes its test menu offers more genes for testing than
its competitors in today’s market, which enables it to provide
expansive options for test customization and clinically actionable
results.
Investor Relations Contacts:The Blueshirt
GroupNicole Borsje, 415-217-2633, nborsje@blueshirtgroup.com
Fulgent Genetics (NASDAQ:FLGT)
Historical Stock Chart
From Aug 2024 to Sep 2024
Fulgent Genetics (NASDAQ:FLGT)
Historical Stock Chart
From Sep 2023 to Sep 2024